GLP-3 Retatrutide (24mg vials)

Description

Retatrutide is a synthetic peptide of interest in metabolic and receptor-signaling research. It is characterized as a triple-receptor agonist, designed to engage the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor within a single molecule. This combined affinity profile makes it a frequently referenced tool compound for investigators examining how incretin and glucagon pathways interact at the cellular and molecular level.

Each unit from Bolt Peptide contains 24mg of Retatrutide presented as a lyophilized powder in a sealed glass vial. The peptide is supplied in its base form without additional conjugation. Researchers typically reconstitute the material in an appropriate sterile solvent prior to use in their experimental protocols.

This compound is of general interest in the following non-clinical research areas:

• Investigation of GLP-1, GIP, and glucagon receptor binding and downstream signaling
• In vitro studies of incretin-pathway crosstalk and metabolic regulation
• Comparative structure-activity studies among multi-agonist peptides
• Assay development and analytical method validation

Material is offered at high purity, with composition assessed by HPLC and mass spectrometry. A batch-specific Certificate of Analysis (COA) accompanies orders to support experimental traceability. For stability, store the sealed lyophilized vial cold and away from light, keep reconstituted solution refrigerated, and avoid repeated freeze-thaw cycles.

Research Use Only: This material is supplied strictly for laboratory research. Not for human or animal consumption. It is not a drug, food, supplement, or cosmetic and has not been approved by the FDA.